Summary of all bronchoalveolar lavage (BAL) CD4+ T-cells that express Vα2.3, Vβ22, and Vα2.3 together with Vβ22; the percentage of Vα2.3+ CD4+ BAL T-cells that express Vβ22, and the percentage of Vβ22+ CD4+ BAL T-cells that express Vα2.3 are also stated
| All patients | HLA-DRB1*03 positive patients | HLA-DRB1*03 negative patients | |
| Patients n | 43 | 26 | 17 |
| Vα2.3+ BAL CD4+ T-cells % | 21.8 (8.5–33.7) | 33.3 (26.5–37.4) | 5.2 (4.3–16.8) |
| Vβ22+ BAL CD4+ T-cells % | 6.0 (3.1–9.8) | 9.2 (7.7–11.5) | 2.3 (1.4–3.2) |
| Vα2.3+/Vβ22+ BAL CD4+ T-cells % | 3.9 (0.5–7.0) | 6.2 (4.9–8.5) | 0.3 (0.2–0.6) |
| Vα2.3+ CD4+ BAL T-cells that express Vβ22 % | 13.7 (6.6–22.9) | 21.0 (16.2–25.6) | 4.2 (2.9–8.0) |
| Vβ22+ CD4+ BAL T-cells that express Vα2.3 % | 46.7 (10.7–61.8) | 62.3 (59.7–69.2) | 9.7 (6.6–13.0) |
Data are presented as median (interquartile range), unless otherwise stated. All figures are shown for the entire patient group as well as for patients with or without HLA-DRB1*03.